Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.
Show more...
執行長
員工
217
國家
US
上市
0 Comments
分享你的想法
FAQ
Harrow Health 11.875% Senior Notes due 2027 今天的股價是多少?▼
HROWM 目前價格為 $26.03 USD,過去 24 小時下跌了 -0.08%。在圖表上更密切關注 Harrow Health 11.875% Senior Notes due 2027 股票的表現。
Harrow Health 11.875% Senior Notes due 2027 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Harrow Health 11.875% Senior Notes due 2027 的股票以代號 HROWM 進行交易。
Harrow Health 11.875% Senior Notes due 2027 的股價在上漲嗎?▼
HROWM 股票較上週上漲 +0%,本月上漲 +0%,但過去一年 Harrow Health 11.875% Senior Notes due 2027 下跌 -1.96%。
Harrow Health 11.875% Senior Notes due 2027 去年的營收是多少?▼
Harrow Health 11.875% Senior Notes due 2027 去年的營收為 199.61MUSD。
Harrow Health 11.875% Senior Notes due 2027 去年的淨利是多少?▼
HROWM 去年的淨收益為 -17.48MUSD。
Harrow Health 11.875% Senior Notes due 2027 會發放股息嗎?▼